Title |
Estimating a constant WTP for a QALY—a mission impossible?
|
---|---|
Published in |
HEPAC Health Economics in Prevention and Care, September 2017
|
DOI | 10.1007/s10198-017-0929-z |
Pubmed ID | |
Authors |
Björn Sund, Mikael Svensson |
Abstract |
Economic evaluations are an important input to decision-making and priority-setting in the health care sector. Measuring preferences for health improvements, as the demand-side value (willingness to pay) of gaining a quality-adjusted life year (QALY), is one relevant component in the interpretation of the results from health economic evaluations. Our article addresses whether willingness to pay for a QALY (WTP-Q) is sensitive to the size of the health differences and the probability for improvement. We use data from a contingent valuation survey based on 1400 respondents conducted in the spring of 2014. The results show that the expectation of sensitivity to scope, or higher WTP to the larger expected quality of life improvement, is not supported. We find WTP-Q values that conform reasonably well to previous studies in Sweden. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 24 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 3 | 13% |
Lecturer | 2 | 8% |
Student > Master | 2 | 8% |
Student > Bachelor | 2 | 8% |
Other | 1 | 4% |
Other | 2 | 8% |
Unknown | 12 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Nursing and Health Professions | 3 | 13% |
Business, Management and Accounting | 2 | 8% |
Economics, Econometrics and Finance | 2 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
Agricultural and Biological Sciences | 1 | 4% |
Other | 3 | 13% |
Unknown | 12 | 50% |